Search Tag: immunotherapy

ICU Management

2019 01 May

A randomised controlled multicentre trial assessed for the first time the safety and pharmacokinetics of an antiprogrammed cell death-ligand 1 (anti–PD-L1) immune checkpoint inhibitor (BMS-936559; Bristol-Myers Squibb, Princeton, NJ) and its effect on immune biomarkers in participants with sepsis-associated immunosuppression. Results show that...Read more

ICU Management

2016 04 Nov

CytoSorbents Corporation , a critical care immunotherapy leader commercializing its flagship  CytoSorb®  extracorporeal cytokine adsorber to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the addition of Belgium and Luxembourg to its direct sales territories.  CytoSorb is now distributed in 42...Read more

ICU Management

2014 13 May

A study recently published in the Journal of Immunology Research reports that patients with highest levels of the most powerful version of the immune molecule HLA-G seem to have the lowest risk of rejecting their transplanted kidney. Dr. Anatolij Horuzsko, immunologist at the Medical College of Georgia at Georgia Regents University and the study's...Read more